A. Roe

Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer.

D. W. Neber, A. Roe, D. W. Nebert, 2001, The Science of the total environment.

The effect of endotoxin on hepatocyte nuclear factor 1 nuclear protein binding: potential implications on CYP2E1 expression in the rat

R. Blouin, S. Poloyac, S. Shedlofsky, 2001, The Journal of pharmacy and pharmacology.

Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice

R. Blouin, J. Snawder, G. Howard, 1999, International Journal of Obesity.

Characterization and Regulation of Angiotensin II Receptors in Rat Adipose Tissue

L. Cassis, U. Shenoy, M. Fettinger, 1996 .

Characterization of nuclear protein binding (AP-1, GR, and STAT) in the genetically obese (fa/fa) Zucker rat.

R. Blouin, G. Howard, A. Roe, 1998, Life sciences.

In vivo phenobarbital treatment increases protein binding to a putative AP-1 site in the CYP2B2 promoter.

R. Blouin, G. Howard, A. Roe, 1996, Biochemical and biophysical research communications.

Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity.

J. Snawder, D. Roberts, R. W. Benson, 1994, Biochemical and biophysical research communications.

HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen.

D. Casciano, J. Snawder, D. Roberts, 1993, Biochemical and biophysical research communications.

Cytochrome P450-dependent metabolism of acetaminophen in four human transgenic lymphoblastoid cell lines.

D. Casciano, J. Snawder, D. Roberts, 1994, Pharmacogenetics.